Authors:
MUHLSCHLEGAL F
FONZI W
HOYER L
PAYNE T
POULET FM
CLEVENGER J
LATGE JP
CALERA J
BEAUVAIS A
PARIS S
MONOD M
STURTEVANT J
GHANNOUM M
NOZAWA Y
CALDERONE R
Citation: F. Muhlschlegal et al., MOLECULAR MECHANISMS OF VIRULENCE IN FUNGUS-HOST INTERACTIONS FOR ASPERGILLUS-FUMIGATUS AND CANDIDA-ALBICANS, MEDICAL MYCOLOGY, 36, 1998, pp. 238-248
Authors:
YOSHIDA Y
KANG K
LEIDICH S
COOPER KD
GHANNOUM M
Citation: Y. Yoshida et al., CANDIDA-ALBICANS INDUCES DIFFERENTIAL CYTOKINE PRODUCTION BY HUMAN BLOOD MONOCYTES, Journal of investigative dermatology, 110(4), 1998, pp. 667-667
Authors:
BELANGER P
NAST CC
FRATTI R
SANATI H
GHANNOUM M
Citation: P. Belanger et al., VORICONAZOLE (UK-109,496) INHIBITS THE GROWTH AND ALTERS THE MORPHOLOGY OF FLUCONAZOLE-SUSCEPTIBLE AND FLUCONAZOLE-RESISTANT CANDIDA SPECIES, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1840-1842
Citation: H. Sanati et al., A NEW TRIAZOLE, VORICONAZOLE (UK-109,496), BLOCKS STEROL BIOSYNTHESISIN CANDIDA-ALBICANS AND CANDIDA-KRUSEI, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2492-2496
Authors:
SANATI H
MESSER SA
PFALLER M
WITT M
LARSEN R
ESPINELINGROFF A
GHANNOUM M
Citation: H. Sanati et al., MULTICENTER EVALUATION OF BROTH MICRODILUTION METHOD FOR SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS AGAINST FLUCONAZOLE, Journal of clinical microbiology, 34(5), 1996, pp. 1280-1282
Authors:
CURRIE BP
GHANNOUM M
BESSEN L
CASADEVALL A
Citation: Bp. Currie et al., DECREASED FLUCONAZOLE SUSCEPTIBILITY OF A RELAPSE CRYPTOCOCCUS-NEOFORMANS ISOLATE AFTER FLUCONAZOLE TREATMENT, Infectious diseases in clinical practice, 4(4), 1995, pp. 318-319